Interest of Performing Two 6-minute Walk Tests at the End of a Pulmonary Rehabilitation Program, in COPD Patients.

NCT05850299 | Completed

• 1 other identifier: 29BRC23.0034 - 2-TM6
• Study Type: observational
• Target: 176
• Locations: 1 country
• Sites: 1

Brief Summary

In pulmonary rehabilitation, the 6-Minute Walk Test (6MWT) is essential to assess the effects of the program on patients' health. Current guidelines don't recommend to perform two 6MWT at the end of pulmonary rehabilitation. However, a more recent study shows that two 6MWT should be performed at the end of the program to accurately and reliably assess patients' capacities. The aim of this study is to compare the results of two tests performed at the end of the program by COPD patients to find out whether there is a benefit of performing two 6MWT at the end of pulmonary rehabilitation.

Conditions

COPD

Keywords

pulmonary rehabilitation; exercise capacity

Outcome Measures

Primary Outcomes (1)

• 6 minute walk distance (6MWD)

  Comparison of the 6MWD between the first and the second 6-Minute walk test (6MWT) performed at the end of pulmonary rehabilitation program.

  Two hours

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

COPD patients admitted for pulmonary rehabilitation program in pulmonary rehabilitation unit of CH des Pays de Morlaix (CHPM).

You may qualify if:

• Patient with stage 2 to 4 (A to D) COPD
• Admitted to pulmonary rehabilitation unit of CH des Pays de Morlaix (CHPM)
• To follow a pulmonary rehabilitation program (4 weeks)
• Patient aged 18 or over
• Patient able to formulate his non-opposition to participate in the study

You may not qualify if:

• Contraindication to perform the 6-Minute Walk Test
• Patient under legal protection
• Refusal of participation

Sponsors & Collaborators

• University Hospital, Brest: lead

Study Sites (1)

Chu Brest

Brest, 29609, France

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Marc BEAUMONT, PhD

  Centre Hospitalier des Pays de Morlaix

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: ECOLOGIC OR COMMUNITY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 28, 2023
• First Posted: May 9, 2023
• Study Start: March 24, 2023
• Primary Completion: April 1, 2024
• Study Completion: April 1, 2024
• Last Updated: September 19, 2025

Record last verified: 2023-03

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: Data will be available beginning three years and ending fifteen years following the final study report completion
• Access Criteria: Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.

Locations

FR (1)